Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
SlideShare a Scribd company logo
Ovulation For ART
HMG/FSH
Chairperson – Madhuri Patil
Aim Of Ovulation Induction
Pharmacological
agents initiate,
augment or
modulate the
hormonal &
gametogenic
response of the
ovary
Overcome natural
follicular selection
process to increase
the number and
quality of oocytes
available for
fertilization
Induction of follicular growth
Time IUI
and OR
Before
starting
ovarian
stimulation
Analysis of the
ovarian reserve
Define goal of
ovarian
stimulation
Select the
correct
stimulation
protocol
Select the correct stimulation protocol
Most Individualized protocols based on following parameters of ORT
COS
Age FSH AMH AFC
Amended
further for BMI
Objective should be to
 Optimize response and
outcomes
 minimizing the risks
OI initiated on Day 2/3 only if
 Follicular size is < 10 mm
 Absence of ovarian cyst
 Endometrial thickness < 6 mm
Pre-requisites for OI
OI drugs should be started on day 2-3 of the MC as
Selection of dominant follicle - early follicular phase
Types Of Ovarian Stimulation For ART
Methods Aim
Natural cycle
(unstimulated /
spontaneous)
No medication Single Oocyte
Modified natural
HCG only
FSH / HMG and GnRh
antagonist add backs
Single Oocyte
Mild or Minimal
Stimulation
Low dose FSH / HMG
Oral compounds
GnRH antagonist
2 – 7 Oocytes
Conventional
standard routine COS
GnRH agonist or
Antagonist
Conventional FSH / HMG
dose
> 8 Oocytes
Scott M. Nelson, Ph.DFertility and Sterility 2013
Protocol Choice based on AMH and AFC
Ovarian response depends on:
presence of other infertility factors
genetic: FSH and LH receptor polymorphism
past performance to COS
risk tolerance
FSH-sensitive follicle cohort
type of stimulation regimen used
type of GnRH analogs used
dose of GT
Choosing the
GnRH
analogues
Non-PCOS
GnRH agonist
Long or short
GnRH antagonist
PCOS
GnRH Antagonist
Fixed and Flexible start
multiple Dose
Single dose Protocol
GnRH Antagonist Protocols
Used in all group of patients
Should be used in all PCOS Women
GnRH agonist Protocols
Norma
Responders
Results in an
uniform
cohort
Poor
Responders
Can cause
premature
rise in P4
GnRH agonist Protocols
Poor
Responders
Poor
Responders
Comparison Between Long GnRH
agonist and Antagonist Protocols
Advantages of Long GnRH agonist Protocol :
Uniform cohort
More oocytes
Increased pregnancy rate
Suitable for normo responders
Disadvantages of Long GnRH agonist
Protocol :
Increased duration of COS
Increased cost
Increased stress – financial / emotional
Increased complication – OHSS
Advantages of Short GnRH agonist Protocol :
Utilizes the initial temporary flare effect for
follicular recruitment followed by pitutory
desensitization
More suitable for older patients and poor
responders
Reduces dose of injection and duration of
COS
Disadvantages of Short GnRH agonist
Protocol :
Unphysiological LH increased in early phase
Reduced pregnancy rates as compared to
long protocol
Advantages of GnRH antagonist Protocol:
Patient friendly – reduced injection and
shorter duration of stimulation
Minimal side effects
Reduce risk of complications – OHSS
Disadvantages of GnRH antagonist Protocol
Uniform cohort of follicles may not develop
Increase in dose of GT may be required one
antagonist initiated:
Ovulation Induction Protocols
Oral ovulogens+ GT
CC/Tamoxifen stimulates recruitment of number of small follicles &
GTs sustains the growth of recruited follicles
Conventional Step-up protocol
Supraphysiological doses of FSH provoke initial development of a large
cohort, stimulate additional follicles, and even rescue those follicles
destined to undergo atresia
Step -down protocol
Monofollicular development achieved
More physiological
Loading FSH dose (100 – 200 IU/d)
decreased by 37.5IU every 3-5 days
Low dose protocol
Chronic Low dose protocol
Treatment cycles long – 28 –35 Days,
Reduced Multiple folliculogenesis and OHSS
Dose increment to a maximum of 225 IU/day
Once dominant follicle emerges, dose of FSH maintained same until the
follicle reaches 18 mm
Step -down protocol
Risk of multi-folliculogenesis and OHSS reduced
FSH threshold dose decreased by 50% when leading follicle 14 mm
Long acting FSH
Predict
response
To tailor
correct
stimulation
regimen
For adequate
response so as
to prevent
complications
To improve
pregnancy
outcomes
Evaluation of Ovarian Reserve Markers
Improve Efficacy, Safety &
Cost Effectiveness of Treatment
Modifying conventional stimulation protocols according to
patients’ characteristics and ovarian reserve makes it patient-
friendly and optimizes the chance of LBR
Take home Message -------

More Related Content

4. OI for ART cycles.pptx

  • 2. Aim Of Ovulation Induction Pharmacological agents initiate, augment or modulate the hormonal & gametogenic response of the ovary Overcome natural follicular selection process to increase the number and quality of oocytes available for fertilization Induction of follicular growth Time IUI and OR
  • 3. Before starting ovarian stimulation Analysis of the ovarian reserve Define goal of ovarian stimulation Select the correct stimulation protocol
  • 4. Select the correct stimulation protocol Most Individualized protocols based on following parameters of ORT COS Age FSH AMH AFC Amended further for BMI Objective should be to  Optimize response and outcomes  minimizing the risks
  • 5. OI initiated on Day 2/3 only if  Follicular size is < 10 mm  Absence of ovarian cyst  Endometrial thickness < 6 mm Pre-requisites for OI OI drugs should be started on day 2-3 of the MC as Selection of dominant follicle - early follicular phase
  • 6. Types Of Ovarian Stimulation For ART Methods Aim Natural cycle (unstimulated / spontaneous) No medication Single Oocyte Modified natural HCG only FSH / HMG and GnRh antagonist add backs Single Oocyte Mild or Minimal Stimulation Low dose FSH / HMG Oral compounds GnRH antagonist 2 – 7 Oocytes Conventional standard routine COS GnRH agonist or Antagonist Conventional FSH / HMG dose > 8 Oocytes
  • 7. Scott M. Nelson, Ph.DFertility and Sterility 2013 Protocol Choice based on AMH and AFC
  • 8. Ovarian response depends on: presence of other infertility factors genetic: FSH and LH receptor polymorphism past performance to COS risk tolerance FSH-sensitive follicle cohort type of stimulation regimen used type of GnRH analogs used dose of GT
  • 9. Choosing the GnRH analogues Non-PCOS GnRH agonist Long or short GnRH antagonist PCOS GnRH Antagonist
  • 10. Fixed and Flexible start multiple Dose Single dose Protocol GnRH Antagonist Protocols Used in all group of patients Should be used in all PCOS Women
  • 11. GnRH agonist Protocols Norma Responders Results in an uniform cohort Poor Responders Can cause premature rise in P4
  • 13. Comparison Between Long GnRH agonist and Antagonist Protocols
  • 14. Advantages of Long GnRH agonist Protocol : Uniform cohort More oocytes Increased pregnancy rate Suitable for normo responders Disadvantages of Long GnRH agonist Protocol : Increased duration of COS Increased cost Increased stress – financial / emotional Increased complication – OHSS Advantages of Short GnRH agonist Protocol : Utilizes the initial temporary flare effect for follicular recruitment followed by pitutory desensitization More suitable for older patients and poor responders Reduces dose of injection and duration of COS Disadvantages of Short GnRH agonist Protocol : Unphysiological LH increased in early phase Reduced pregnancy rates as compared to long protocol Advantages of GnRH antagonist Protocol: Patient friendly – reduced injection and shorter duration of stimulation Minimal side effects Reduce risk of complications – OHSS Disadvantages of GnRH antagonist Protocol Uniform cohort of follicles may not develop Increase in dose of GT may be required one antagonist initiated:
  • 15. Ovulation Induction Protocols Oral ovulogens+ GT CC/Tamoxifen stimulates recruitment of number of small follicles & GTs sustains the growth of recruited follicles
  • 16. Conventional Step-up protocol Supraphysiological doses of FSH provoke initial development of a large cohort, stimulate additional follicles, and even rescue those follicles destined to undergo atresia
  • 17. Step -down protocol Monofollicular development achieved More physiological Loading FSH dose (100 – 200 IU/d) decreased by 37.5IU every 3-5 days
  • 19. Chronic Low dose protocol Treatment cycles long – 28 –35 Days, Reduced Multiple folliculogenesis and OHSS Dose increment to a maximum of 225 IU/day Once dominant follicle emerges, dose of FSH maintained same until the follicle reaches 18 mm
  • 20. Step -down protocol Risk of multi-folliculogenesis and OHSS reduced FSH threshold dose decreased by 50% when leading follicle 14 mm
  • 22. Predict response To tailor correct stimulation regimen For adequate response so as to prevent complications To improve pregnancy outcomes Evaluation of Ovarian Reserve Markers Improve Efficacy, Safety & Cost Effectiveness of Treatment
  • 23. Modifying conventional stimulation protocols according to patients’ characteristics and ovarian reserve makes it patient- friendly and optimizes the chance of LBR Take home Message -------